Prolonged opioid antagonism with naloxone in chronic renal failure

被引:11
作者
Hanes, SD
Franklin, M
Kuhl, DA
Headley, AS
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA
[2] Univ Tennessee, Div Med Pulm & Crit Care, Memphis, TN USA
[3] Univ Oxford, Psychopharmacotherapy Res Unit, Oxford, England
来源
PHARMACOTHERAPY | 1999年 / 19卷 / 07期
关键词
D O I
10.1592/phco.19.10.897.31557
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Respiratory depression secondary to morphine intoxication occurred in an elderly patient with chronic renal failure (CRF). It was reversed with a continuous infusion of naloxone. Approximately 11 hours after the infusion was discontinued, the patient relapsed into respiratory depression consistent with opioid intoxication. He was rechallenged with a naloxone infusion with resolution of the opioid effects. This case suggests prolonged antagonism of opioid effects inconsistent with naloxone's reported pharmacologic effects. Serum naloxone concentrations measured after the end of the infusion suggest that the drug's pharmacokinetics were significantly altered. Further research is necessary to characterize pharmacokinetic changes that occur in CRF. In the absence of this information, similar patients should be closely monitored for relapse of respiratory depression after naloxone is discontinued.
引用
收藏
页码:897 / 901
页数:5
相关论文
共 22 条
[1]   METABOLISM OF DRUGS BY THE KIDNEY [J].
ANDERS, MW .
KIDNEY INTERNATIONAL, 1980, 18 (05) :636-647
[2]   NALOXONE PROTEIN-BINDING IN ADULT AND FETAL PLASMA [J].
ASALI, LA ;
BROWN, KF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (04) :459-463
[3]   SEVERE RESPIRATORY DEPRESSION FROM PATIENT-CONTROLLED ANALGESIA IN RENAL-FAILURE [J].
COVINGTON, EC ;
GONSALVESEBRAHIM, L ;
CURRIE, KO ;
SHEPARD, KV ;
PIPPENGER, CE .
PSYCHOSOMATICS, 1989, 30 (02) :226-228
[4]  
FISHMAN J, 1973, J PHARMACOL EXP THER, V187, P575
[5]   Determination of naloxone in human plasma by high-performance liquid chromatography with coulometric detection [J].
Franklin, M ;
Odontiadis, J .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 679 (1-2) :199-203
[6]  
FUJIMOTO JM, 1975, P SOC EXP BIOL MED, V148, P443
[7]   PHARMACOKINETICS OF MORPHINE AND ITS SURROGATES .8. NALOXONE AND NALOXONE CONJUGATE PHARMACOKINETICS IN DOGS AS A FUNCTION OF DOSE AND AS AFFECTED BY SIMULTANEOUSLY ADMINISTERED MORPHINE [J].
GARRETT, ER ;
SHYU, WC ;
ULUBELEN, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (12) :1127-1136
[8]   CLINICAL PHARMACOKINETICS OF MORPHINE [J].
GLARE, PA ;
WALSH, TD .
THERAPEUTIC DRUG MONITORING, 1991, 13 (01) :1-23
[9]   A DOSING NOMOGRAM FOR CONTINUOUS INFUSION INTRAVENOUS NALOXONE [J].
GOLDFRANK, L ;
WEISMAN, RS ;
ERRICK, JK ;
LO, MW .
ANNALS OF EMERGENCY MEDICINE, 1986, 15 (05) :566-570
[10]   ANTINOCICEPTIVE AND VENTILATORY EFFECTS OF THE MORPHINE METABOLITES - MORPHINE-6-GLUCURONIDE AND MORPHINE-3-GLUCURONIDE [J].
GONG, QL ;
HEDNER, T ;
HEDNER, J ;
BJORKMAN, R ;
NORDBERG, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 193 (01) :47-56